Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy
- 1 June 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 152 (6), 1256-1262
- https://doi.org/10.1016/j.pain.2011.01.005
Abstract
Some expert guidelines recommend time-scheduled opioid dosing over pain-contingent dosing for patients receiving chronic opioid therapy (COT). The premise is that time-scheduled dosing results in more stable opioid blood levels and better pain relief, fewer adverse effects, less reinforcement of pain behaviors, and lower addiction risk. We report results of a survey of 1781 patients receiving COT for chronic noncancer pain, in which 967 reported time-scheduled opioid dosing only and 325 reported pain-contingent opioid dosing only. Opioid-related problems and concerns were assessed with the Prescribed Opioids Difficulties Scale. We hypothesized that respondents using time-scheduled opioid dosing would report significantly fewer problems and concerns than those using pain-contingent dosing. Patients receiving time-scheduled dosing received substantially higher average daily opioid doses than those using pain-contingent dosing (97.2 vs. 37.2 mg average daily dose morphine equivalents, P < .0001). Contrary to expectation, time-scheduled opioid dosing was associated with higher levels of patient opioid control concerns than pain-contingent dosing (6.2 vs. 4.8, P = .008), after adjusting for patient and drug regimen differences. Opioid-related psychosocial problems were somewhat greater among patients using time-scheduled dosing, but this difference was nonsignificant after controlling for patient and drug regimen differences (5.9 vs. 5.0, P = .14). Time-scheduled dosing typically involved higher dosage levels and was associated with higher levels of patient concerns about opioid use. Controlled comparative effectiveness research is needed to assess benefits and risks of time-scheduled opioid dosing relative to pain-contingent opioid dosing among COT patients in ambulatory care. Patients with time-scheduled dosing received higher opioid dosage than patients with pain-contingent dosing. Time-scheduled dosing was associated with greater opioid control concerns than pain-contingent dosing.Keywords
This publication has 20 references indexed in Scilit:
- Hydrogen site location in ultrathin vanadium layers by N-15 nuclear reaction analysisNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 2019
- Emergency Department Visits Among Recipients of Chronic Opioid TherapyJAMA Internal Medicine, 2010
- The Prescribed Opioids Difficulties ScaleThe Clinical Journal of Pain, 2010
- Opioid Prescriptions for Chronic Pain and OverdoseAnnals of Internal Medicine, 2010
- Trends in long‐term opioid therapy for chronic non‐cancer painPharmacoepidemiology and Drug Safety, 2009
- ‘Scheduled’ dosing of lornoxicam provides analgesia superior to that provided by ‘on request’ dosing following craniotomyEuropean Journal of Anaesthesiology, 2009
- Pharmacological Management of Persistent Pain in Older PersonsJournal of the American Geriatrics Society, 2009
- Multi-modal, Pre-emptive Analgesia Decreases the Length of Hospital Stay Following Total Joint ArthroplastyOrthopedics, 2009
- Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer PainThe Journal of Pain, 2009
- Use of Opioid Analgesics for the Treatment of Chronic Noncancer Pain - A Consensus Statement and Guidelines from the Canadian Pain Society, 2002Pain Research and Management, 2003